PS8 - 40. The effect of three- versus six-monthly monitoring on cardiometabolic control in well-controlled type 2 diabetes patients: a pragmatic randomised controlled equivalence trial in primary care (EFFIMODI study)
Paulien R. Wermeling(University Medical Center Utrecht), Guy E.H.M. Rutten(University Medical Center Utrecht), Rebecca K. Stellato(University Medical Center Utrecht), Joline W.J. Beulens(Heidelberg University), Kees Gorter(Heidelberg University)
Cited by 0
Related Papers
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
|Social Science & Medicine|2001|648
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study.
|Diabetes Care|2000|618
Is there an association between menopause status and sexual functioning?
|Menopause The Journal of The North American Menopause Society|2000|304
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
|AIDS|2001|255
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
|Cardiovascular Diabetology|2021|204